Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 32
Filter
1.
Arterioscler Thromb Vasc Biol ; 21(5): 739-45, 2001 May.
Article in English | MEDLINE | ID: mdl-11348868

ABSTRACT

Reactive oxygen species (ROS), produced by cellular constituents of the arterial wall, provide a signaling mechanism involved in vascular remodeling. Because adventitial fibroblasts are actively involved in coronary remodeling, we examined whether the changes in the redox state affect their phenotypic characteristics. To this end, superoxide anion production and NAD(P)H oxidase activity were measured in porcine coronary arteries in vivo, and the effect of ROS generation on adventitial fibroblast proliferation was examined in vitro. Superoxide production (SOD- and Tiron-inhibitable nitro blue tetrazolium [NBT] reduction) increased significantly within 24 hours after balloon-induced injury, with the product of NBT reduction present predominantly in adventitial fibroblasts. These changes were NAD(P)H oxidase-dependent, because diphenyleneiodonium (DPI) abolished superoxide generation (P<0.001). Furthermore, the injury-induced superoxide production was associated with augmented NAD(P)H oxidase activity and upregulation of p47(phox) and p67(phox) in adventitial fibroblasts (immunohistochemistry). Serum stimulation of isolated adventitial fibroblasts produced time-dependent increases in ROS production (peak 3 to 6 hours). The inhibition of ROS generation with NAD(P)H oxidase inhibitor (DPI) or the removal of ROS with antioxidants (Tiron, catalase) abrogated proliferation of adventitial fibroblasts. These results indicate that vascular NAD(P)H oxidase plays a central role in the upregulation of oxidative stress after coronary injury, providing pivotal growth signals for coronary fibroblasts.


Subject(s)
Catheterization/adverse effects , Coronary Vessels/enzymology , Coronary Vessels/injuries , Fibroblasts/enzymology , NADH, NADPH Oxidoreductases/metabolism , Reactive Oxygen Species/metabolism , Animals , Cell Division , Cells, Cultured , Coronary Vessels/cytology , Culture Media , Culture Techniques , Female , Fibroblasts/cytology , NADPH Oxidases , Oxidative Stress , Phosphoproteins/metabolism , Reactive Oxygen Species/physiology , Superoxides/metabolism , Swine
2.
Circulation ; 103(19): 2408-13, 2001 May 15.
Article in English | MEDLINE | ID: mdl-11352892

ABSTRACT

BACKGROUND: Because saphenous vein grafts (SVGs) exhibit greater cellular heterogeneity and worse clinical outcomes than arterial grafts (AGs), we examined oxidative stress and lipid retention in different vascular conduits. METHODS AND RESULTS: In a porcine model of graft interposition into carotid artery, superoxide anion (.O(2)(-)) was measured at 2 weeks after surgery. SVGs demonstrated increased.O(2)(-) production compared with AGs (SOD-inhibitable nitro blue tetrazolium reduction, P<0.01). The NAD(P)H oxidase inhibitor diphenyleneiodonium (P<0.01) abolished SVG-derived.O(2)(-), whereas the inhibitors of other pro-oxidant enzymes were ineffective. The change in oxidative stress was also reflected by lower activity of the endogenous antioxidant superoxide dismutase in SVGs than in AGs (P<0.001). SVG remodeling was associated with increased synthesis of sulfated glycosaminoglycans and augmented expression of a core protein, versican. These changes were accompanied by SVGs retaining significantly more (125)I-labeled LDL than AGs ex vivo (P<0.001). In hyperlipemic animals, lipid accumulation and oxidized epitopes were preferentially noted in the intima of SVGs at 1 month after surgery. CONCLUSIONS: This study demonstrated significant differences in the biology of SVGs and AGS: SVGs exhibited higher oxidative stress, LDL accumulation, and the presence of oxidized epitopes. These findings suggest that proatherogenic changes in SVGs may commence early after surgical revascularization.


Subject(s)
Blood Vessels/metabolism , Lipid Metabolism , Oxidative Stress , Superoxides/metabolism , Animals , Arteries/drug effects , Arteries/metabolism , Arteries/transplantation , Blood Vessels/drug effects , Blood Vessels/transplantation , Enzyme Inhibitors/pharmacology , Glycosaminoglycans/metabolism , In Vitro Techniques , Lipoproteins, LDL/metabolism , NG-Nitroarginine Methyl Ester/pharmacology , Onium Compounds/pharmacology , Oxypurinol/pharmacology , Proteoglycans/metabolism , Rotenone/pharmacology , Saphenous Vein/drug effects , Saphenous Vein/metabolism , Saphenous Vein/transplantation , Sulfates/metabolism , Superoxide Dismutase/metabolism , Swine
3.
Circ Res ; 88(3): 352-8, 2001 Feb 16.
Article in English | MEDLINE | ID: mdl-11179205

ABSTRACT

There is increasing evidence to suggest that coronary smooth muscle cells (SMCs) differ from noncoronary SMCs. As integrin adhesion molecules regulate many SMC functions, we hypothesized that differences in integrin expression on coronary and noncoronary SMCs may account for cellular differences. Analysis of integrin expression on freshly isolated porcine coronary and noncoronary SMCs revealed that coronary SMCs express significantly less alpha(5)beta(1) than noncoronary SMCs, whereas the expression of total beta(1) and that of alpha(v)beta(3) are similar. Consistent with these findings, coronary SMCs demonstrated significantly less adhesion to fibronectin, compared with carotid artery SMCs. As alpha(5)beta(1)-mediated signaling has been associated with cellular proliferation, the effects of differential alpha(5)beta(1) expression on cell proliferation were examined by comparing primary coronary and carotid artery SMC proliferation. Coronary SMC growth was significantly lower than that of carotid artery SMCs when plated on fibronectin or type I collagen. Blocking alpha(5)beta(1) function on carotid artery SMCs produced a significant decrease in cellular proliferation, resulting in growth similar to that of coronary SMCs. Furthermore, blocking alpha(5)beta(1), but not alpha(v)beta(3), inhibited loss of alpha-smooth muscle actin in proliferating SMCs. Proliferating coronary SMCs were found to upregulate alpha(5)beta(1) expression, further indicating a role for alpha(5)beta(1) in SMC growth. These results suggest that dissimilar alpha(5)beta(1) integrin expression may mediate regional differences in phenotype of vascular SMCs.


Subject(s)
Carotid Arteries/metabolism , Coronary Vessels/metabolism , Disintegrins , Integrins/metabolism , Animals , Carotid Arteries/cytology , Carotid Arteries/drug effects , Cell Adhesion/drug effects , Cell Differentiation/drug effects , Cell Division/drug effects , Collagen/pharmacology , Coronary Vessels/cytology , Coronary Vessels/drug effects , Dose-Response Relationship, Drug , Fibronectins/pharmacology , Integrins/drug effects , Integrins/physiology , Muscle, Smooth, Vascular/cytology , Muscle, Smooth, Vascular/drug effects , Muscle, Smooth, Vascular/physiology , Peptides/pharmacology , Receptors, Fibronectin/metabolism , Receptors, Fibronectin/physiology , Swine , Viper Venoms/pharmacology
4.
J Vasc Res ; 37(5): 399-407, 2000.
Article in English | MEDLINE | ID: mdl-11025403

ABSTRACT

Myofibroblasts of adventitial origin have been linked to neointimal formation and remodeling after coronary injury. Accordingly, the goal of this study was to examine whether myofibroblasts contribute to focal accumulation of glycosaminoglycans (GAGs) and lipids during coronary repair. GAG synthesis was assessed by ex vivo labeling of balloon-injured porcine coronary arteries with (14)C-glucosamine. The synthesis of total GAGs transiently increased at 8 days in the normolipemic model (a 2.2-fold increase over baseline, p < 0.05). The majority of newly synthesized GAGs were sensitive to chondroitin ABC lyase (chondroitin/dermatan sulfate GAGs). Versican was localized to myofibroblast-rich regions in the adventitia and neointima [positive for alpha-smooth muscle (SM) actin, negative for h-caldesmon and SM myosin heavy chain]. In contrast, the adjacent SM-rich media showed no increase in versican expression. The association between injury-induced GAG accumulation and lipid retention was examined at 2 weeks after coronary injury in the hyperlipemic model. Lipid (Oil Red O) accumulated in the neointima and adventitia, but not in the adjacent media. Coronary repair under hyperlipemic conditions was associated with macrophage infiltration (19 +/- 5 vs. 3 +/- 2% of neointimal cells in normolipemic animals, p < 0.001) and increased neointimal formation (1.8 +/- 0.5 vs. 1.0 +/- 0.3 mm(2) in normolipemic animals, p < 0.01). In conclusion, this study demonstrated a transient increase in GAG synthesis following coronary injury. Chondroitin sulfate proteoglycans (e.g., versican) were rapidly synthesized by activated adventitial and neointimal cells which could contribute to early lipid retention in injured vessels.


Subject(s)
Coronary Vessels/injuries , Fibroblasts/physiology , Glycosaminoglycans/biosynthesis , Lipid Metabolism , Muscle, Smooth, Vascular/physiology , Animals , Azo Compounds , Catheterization , Chondroitin Sulfate Proteoglycans/analysis , Chondroitin Sulfate Proteoglycans/biosynthesis , Chondroitin Sulfates/analysis , Colorimetry , Coloring Agents , Coronary Vessels/chemistry , Coronary Vessels/metabolism , Dermatan Sulfate/analysis , Glycosaminoglycans/analysis , Immunohistochemistry , Kinetics , Lectins, C-Type , Muscle, Smooth, Vascular/cytology , Swine , Versicans
5.
Circulation ; 101(5): 524-32, 2000 Feb 08.
Article in English | MEDLINE | ID: mdl-10662750

ABSTRACT

BACKGROUND: Recent findings suggesting the involvement of adventitial cells in coronary repair have raised questions regarding the phenotypic "plasticity" of medial smooth muscle cells (SMCs). Accordingly, the aims of the present study were to examine the characteristics of coronary medial and adventitial cells and to compare the responses of coronary and noncoronary SMCs to stimulation. METHODS AND RESULTS: Enzymatically isolated coronary SMCs (human and porcine) were distinct from noncoronary SMCs, showing poor adhesion and spreading, as well as lower proliferation, collagen synthesis, and LDL degradation. Several extracellular matrix components (Matrigel, collagen I and IV, laminin, vitronectin, fibronectin) or growth factors (epidermal growth factor, platelet-derived growth factor-BB, insulin growth factor-1, interleukin-1alpha) failed to augment the adhesion or proliferation of coronary SMCs to the levels observed in noncoronary SMCs. Unlike coronary SMCs, coronary fibroblasts demonstrated high adhesion, proliferation, collagen synthesis, and avid LDL metabolism. Limited responses of coronary SMCs were associated with sustained expression of differentiation markers (alpha-smooth muscle actin, h-caldesmon, and smooth muscle myosin heavy chain), whereas noncoronary SMCs showed marked phenotypic heterogeneity. CONCLUSIONS: Coronary SMCs appeared to maintain highly differentiated phenotype in response to stimulation, whereas coronary adventitial fibroblasts demonstrated several characteristics that are essential during vascular repair. Coronary SMCs, however, were distinct from noncoronary medial cells, which displayed greater phenotypic heterogeneity and versatility in culture. We postulate that the mechanism of vascular repair may differ among vascular beds, pointing to the importance of coronary artery-specific investigations in vascular biology.


Subject(s)
Coronary Vessels/cytology , Fibroblasts/cytology , Muscle, Smooth, Vascular/cytology , Biomarkers , Cell Adhesion , Cell Differentiation , Cell Division , Cell Size , Collagen/biosynthesis , Coronary Vessels/metabolism , Fibroblasts/metabolism , Fibroblasts/physiology , Humans , In Vitro Techniques , Lipoproteins, LDL/metabolism , Muscle, Smooth, Vascular/metabolism
6.
Arterioscler Thromb Vasc Biol ; 19(5): 1150-5, 1999 May.
Article in English | MEDLINE | ID: mdl-10323763

ABSTRACT

The migration of vascular cells is regulated by matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs). Because the activation of adventitial fibroblasts has been implicated in coronary repair, we have examined regional differences in cell outgrowth and the synthesis of MMPs/TIMPs in different layers of porcine coronary arteries. Coronary medial explants demonstrated significantly slower cell outgrowth than coronary adventitia in culture (P<0.001). These observations were paralleled by the predominant expression of TIMP-1 and -2 in the media (14-fold and 37-fold higher than in adventitia, respectively, P<0.001), whereas higher gelatinolytic activities (MMP-2 and -9) were released from adventitial explants. Smooth muscle cell outgrowth from the media was regulated by endogenous TIMPs, since TIMP inhibition (recombinant MMP-2 or neutralizing anti-TIMP antibodies) facilitated cell outgrowth (P<0.001). In contrast, the addition of recombinant TIMP-1 or -2 decreased adventitial cell outgrowth. In the coculture experiments, the presence of coronary media retarded adventitial cell outgrowth, whereas medial damage abrogated these effects, allowing for fibroblast migration (P<0.001). In conclusion, this study demonstrated differential migratory properties and distinct MMP/TIMP synthesis by coronary fibroblasts and smooth muscle cells. Endogenous TIMPs in the media may play an important role in maintaining coronary arterial wall homeostasis, whereas high levels of matrix-degrading activities confer the "invasive" characteristics of adventitial fibroblasts.


Subject(s)
Collagenases/physiology , Coronary Vessels/cytology , Gelatinases/physiology , Metalloendopeptidases/physiology , Tissue Inhibitor of Metalloproteinase-1/physiology , Tissue Inhibitor of Metalloproteinase-2/physiology , Animals , Cell Movement/drug effects , Cells, Cultured , Collagenases/pharmacology , Connective Tissue Cells/drug effects , Connective Tissue Cells/physiology , Culture Media, Conditioned/pharmacology , Female , Fibroblasts/drug effects , Fibroblasts/physiology , Gelatinases/pharmacology , Homeostasis , Matrix Metalloproteinase 2 , Matrix Metalloproteinase 9 , Metalloendopeptidases/pharmacology , Recombinant Fusion Proteins/pharmacology , Swine , Tissue Inhibitor of Metalloproteinase-1/pharmacology , Tissue Inhibitor of Metalloproteinase-2/pharmacology , Tunica Media/cytology
7.
Circulation ; 96(9): 2854-8, 1997 Nov 04.
Article in English | MEDLINE | ID: mdl-9386149

ABSTRACT

BACKGROUND: PTCA of an infarct-related lesion is associated with a high rate of restenosis and/or vessel occlusion. Recent studies have shown that coronary stenting in patients with stable or unstable angina is associated with a significant reduction in the restenosis rate compared with conventional balloon angioplasty. However, no information is available concerning the long-term effect of coronary stenting at infarct-related lesions compared with balloon angioplasty alone. METHODS AND RESULTS: One hundred consecutive patients undergoing stent implantation at an infarct-related lesion and systematic 6-month angiographic follow-up were matched for major pre-PTCA clinical and angiographic variables with a group of patients undergoing conventional angioplasty. Preprocedural, postprocedural, and 6-month follow-up angiograms were analyzed with quantitative angiography. Coronary stenting was performed as a bailout procedure after failed balloon angioplasty in 20%, for a suboptimal result after balloon angioplasty in 71%, and electively in 9%. Stent implantation was associated with a higher acute gain than balloon angioplasty. At follow-up, the minimal lumen diameter was significantly (P<.0001) larger in the stent group (1.72+/-0.69 versus 1.23+/-0.72 mm). Restenosis (>50% DS at follow-up) occurred in 27% of the stent group versus 52% of the balloon group (P<.005). At follow-up, total occlusion at the dilated site occurred in 1% of the stent group versus 14% of the balloon group (P<.005). CONCLUSIONS: Coronary stenting of infarct-related lesions is associated with a highly beneficial effect on 6-month angiographic outcome compared with balloon angioplasty alone. Further studies are needed to establish whether the beneficial effect of coronary stenting on long-term vessel patency is associated with an improvement in left ventricular function or in clinical outcome.


Subject(s)
Angioplasty, Balloon, Coronary/adverse effects , Coronary Disease/prevention & control , Myocardial Infarction/therapy , Stents , Adult , Aged , Coronary Angiography , Female , Follow-Up Studies , Humans , Male , Middle Aged , Recurrence
8.
Environ Health Perspect ; 104 Suppl 6: 1251-6, 1996 Dec.
Article in English | MEDLINE | ID: mdl-9118901

ABSTRACT

Chronic exposure of humans of benzene affects hematopoietic stem and progenitor cells and leads to aplastic anemia. The stromal macrophage, a target of benzene toxicity, secretes interleukin-1 (IL-1), which induces the stromal fibroblast to synthesize hematopoietic colony-stimulating factors. In a mouse model, benzene causes an acute marrow hypocellularity that can be prevented by the concomitant administration of IL-1 alpha. The ability of benzene to interfere with the production and secretion of IL-1 alpha was tested. Stromal macrophages from benzene-treated mice were capable of the transcription to the IL-1 alpha gene and the translation of the message but showed an inability to process the 34-kDa pre-IL-1 alpha precursor to the 17-kDa biologically active cytokine. Treatment of normal murine stromal macrophages in culture with hydroquinone (HQ) also showed an inhibition in processing of pre-IL-1 alpha. Hydroquinone is oxidized by a peroxidase-mediated reaction in the stromal macrophage to p-benzoquinone, which interacts with the sulfhydryl (SH) groups of proteins and was shown to completely inhibit the activity of calpain, the SH-dependent protease that cleaves pre-IL-1 alpha. In a similar manner, HQ, via peroxidase oxidation to p-benzoquinone, was capable of preventing the IL-1 beta autocrine stimulation of growth of human B1 myeloid tumor cells by preventing the processing of pre-IL-1 beta to mature cytokine. Benzoquinone was also shown to completely inhibit the ability of the SH-dependent IL-1 beta converting enzyme. Thus benzene-induced bone marrow hypocellularity may result from apoptosis of hematopoietic progenitor cells brought about by lack of essential cytokines and deficient IL-1 alpha production subsequent to the inhibition of calpain by p-benzoquinone and the prevention of pre-IL-1 processing.


Subject(s)
Benzene/metabolism , Benzene/toxicity , Benzoquinones/metabolism , Benzoquinones/toxicity , Calpain/antagonists & inhibitors , Cysteine Endopeptidases/metabolism , Interleukin-1/metabolism , Protein Precursors/metabolism , Animals , Bone Marrow/drug effects , Bone Marrow/metabolism , Bone Marrow Cells , Caspase 1 , Cell Line , Enzyme Inhibitors/toxicity , Humans , Indomethacin/pharmacology , Interleukin-1/genetics , Interleukin-1/pharmacology , Mice , Protein Precursors/genetics , Protein Processing, Post-Translational/drug effects , Recombinant Proteins/pharmacology
9.
Environ Health Perspect ; 104 Suppl 6: 1257-64, 1996 Dec.
Article in English | MEDLINE | ID: mdl-9118902

ABSTRACT

Chronic exposure of humans to benzene causes acute myelogenous leukemia (AML). The studies presented here were undertaken to determine whether benzene, or its reactive metabolite, hydroquinone (HQ), affects differentiation of myeloblasts. Benzene or HQ administered to C57BL/6J mice specifically induced granulocytic differentiation of myeloblasts. The ability of these compounds to induce differentiation of the myeloblasts was tested directly using the murine interleukin 3 (IL-3)-dependent 32D.3 (G) myeloblastic cell line, and the human HL-60 promyelocytic leukemia cell line. We have previously shown that benzene treatment of HL-60 myeloblasts activates protein kinase C (PKC) and upregulates the 5-lipoxygenase (LPO) pathway for the production of leukotriene D4 (LTD4), an essential effector or granulocytic differentiation. Differentiation was prevented by sphinganine, a PKC inhibitor, and, as shown here, by LPO inhibitors and LTD4 receptor antagonists. Benzene or HQ also induces differentiation in 32D.3 (G) myeloblasts. Both compounds interact with cellular signaling pathways normally activated by granulocyte colony stimulating factor (G-CSF) and can replace the requirement for G-CSF. While IL-3 induces a growth response in 32D.3 (G) cells, G-CSF has been shown to provide both growth and differentiated signals. Both HQ and LTD4 induce differentiation and synergize with IL-3 for growth; however, neither supports growth in the absence of IL-3. Benzene, like HQ, also provides a differentiation signal for 32D cells; however, it has no effect on their growth. Unlike G-CSF, benzene, or LTD4, each of which stimulates terminal differentiation; HQ blocks differentiation at the myelocyte stage, allowing only a small percentage of progenitors to proceed to mature segmented granulocytes. Benzene- and G-CSF-induced differentiation were prevented by the additional of either LPO inhibitors or LTD4 receptor antagonists, indicating that benzene, like G-CSF, upregulates LTD4 production. Hydroquinone-induced differentiation was not affected by the LPO inhibitors, but only by the specific receptor antagonists. Thus HQ appears to obviate the requirement for LTD4 by activating the LTD4 receptor directly.


Subject(s)
Benzene/toxicity , Carcinogens/toxicity , Granulocytes/cytology , Granulocytes/drug effects , Hydroquinones/toxicity , Membrane Proteins , Receptors, Leukotriene , Animals , Arachidonate 5-Lipoxygenase/metabolism , Benzene/metabolism , Carcinogens/metabolism , Cell Differentiation/drug effects , Granulocytes/metabolism , HL-60 Cells , Humans , Hydroquinones/metabolism , Leukemia, Myeloid, Acute/chemically induced , Leukotriene Antagonists , Leukotriene D4/pharmacology , Lipoxygenase Inhibitors/pharmacology , Male , Mice , Mice, Inbred C57BL , Protein Kinase C/metabolism
10.
Rom J Intern Med ; 34(3-4): 183-8, 1996.
Article in French | MEDLINE | ID: mdl-9221050

ABSTRACT

Samples of peripheral blood were taken from 11 patients (blood group A, B and O), suffering from acute myeloblastic leukemia (AML), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS), before and after chemotherapy, compared to normal control samples. The RBC's typing was done by standard agglutination technique (with conventional human and murine anti-sera) and flow cytometry. While using different reagent dilutions, a lower expression of the A or B antigen was noticed in all patients, even if direct typing of the RBC's revealed an apparently normal pattern. The most important depletion of antigenic expression was found to correspond to the highest concentration of myeloblasts in the bone marrow, with hypoplastic erythrocytic series. The modified H reactivity, detected at admission, was still present after complete remission, as an expression of the residual disease. Studies of the H expression could eventually become a parameter of evaluating the moment of relapse of the myeloproliferative disease.


Subject(s)
ABO Blood-Group System/immunology , Anemia, Refractory, with Excess of Blasts/blood , Erythrocytes/immunology , Leukemia, Myeloid, Acute/blood , Precursor Cell Lymphoblastic Leukemia-Lymphoma/blood , Agglutination Tests , Flow Cytometry , Humans
12.
Chem Biol Interact ; 98(3): 211-22, 1995 Dec 22.
Article in English | MEDLINE | ID: mdl-8548860

ABSTRACT

Chronic exposure of humans to benzene causes severe bone marrow cell depression leading to aplastic anemia. Marrow stromal macrophage dysfunction and deficient interleukin-1 production has been reported for patients with severe aplastic anemia. The stromal macrophage, a target of benzene toxicity, is involved in hematopoietic regulation through the synthesis of several cytokines including interleukin-1, which is required for production by stromal fibroblasts of a number of cytokines required for the survival of hematopoietic progenitor cells. We have previously demonstrated that hydroquinone, a major toxic metabolite of benzene in marrow, prevents the proteolytic conversion of 31 kDa pre-interleukin-1 alpha to the 17 kDa cytokine by calpain in purified murine stromal macrophages. Furthermore, stromal macrophages from benzene-treated mice produce the 31 kDa pre-interleukin-1 alpha when stimulated in culture with endotoxin, but cannot convert the precursor to interleukin-1 alpha. In this report, we show that 1,4-benzoquinone, the oxidation product of hydroquinone in the cell, causes a concentration-dependent inhibition of highly purified human platelet calpain with an IC50 of 3 microM. Hydroquinone also inhibits the processing of pre-interleukin-1 beta by interleukin-1 beta convertase. The addition of 2 microM hydroquinone to B1 cells that undergo autocrine stimulation by interleukin-1 beta resulted in the cessation of autocrine cell growth and interleukin-1 beta secretion into the culture medium, as determined by Western immunoblots of the culture supernatants. Purified converting enzyme treated with 3 microM benzoquinone was incapable of converting 31 kDa recombinant pre-interleukin-1 beta to the 17 kDa mature cytokine as analyzed by polyacrylamide gel electrophoresis and Western immunoblotting. These findings support our observations in a mouse model that benzene-induced bone marrow cell depression results from a lack of interleukin-1 alpha subsequent to an inhibition by benzoquinone of calpain, the protease required for converting pre-interleukin-1 alpha to active cytokine. The results may provide a basis for studying benzene-induced aplastic anemia in a mouse model.


Subject(s)
Benzoquinones/toxicity , Calpain/antagonists & inhibitors , Cysteine Endopeptidases/metabolism , Interleukin-1/metabolism , Protein Precursors/metabolism , Benzene/metabolism , Benzene/toxicity , Blotting, Western , Caspase 1 , Cell Division/drug effects , Cysteine Proteinase Inhibitors/toxicity , Humans , Hydroquinones/toxicity , Indomethacin/toxicity , Macrophages/drug effects , Macrophages/metabolism , Recombinant Proteins/metabolism , Tumor Cells, Cultured
13.
Stem Cells ; 13(3): 295-310, 1995 May.
Article in English | MEDLINE | ID: mdl-7542115

ABSTRACT

Chronic exposure of humans to benzene (BZ) causes acute myelogenous leukemia. These studies determined whether BZ, or its reactive metabolite, hydroquinone (HQ), affect differentiation of myeloblasts. BZ or HQ administered to C57BL/6J mice specifically induced terminal granulocytic differentiation of myeloblasts. The ability of the compounds to induce differentiation of the myeloblast was tested directly using the murine interleukin 3 (IL-3)-dependent myeloblastic cell line, 32D.3 (G) and the human HL-60 promyelocytic leukemic cell line. Treatment of HL-60 myeloblasts with BZ activated protein kinase C and upregulated the 5-lipoxygenase (LPO) pathway for the production of leukotriene D4 (LTD4), an essential effector of granulocytic differentiation. Differentiation was prevented by sphinganine, a kinase C inhibitor, as well as by LPO inhibitors and LTD4 receptor antagonists. BZ and HQ also induced differentiation in 32D.3 (G) myeloblasts. Both compounds interact with cellular signaling pathways activated by granulocyte colony-stimulating factor (G-CSF) and thus replace the requirement for G-CSF. IL-3 induces a growth response, whereas G-CSF provides both growth and differentiation signals. BZ does not induce growth in the absence of IL-3, but provides a differentiation signal. Both HQ and LTD4 induce differentiation and synergize with IL-3 for growth, however, neither support growth in the absence of IL-3. BZ-induced 32D cells showed a gradual progression of progenitor differentiation to granulocytes similar to that seen with G-CSF or LTD4. HQ blocks differentiation at the myelocyte stage; only a small percentage of progenitors proceed to granulocytes. BZ, like G-CSF, upregulates LTD4 production, whereas HQ obviates the requirement for LTD4 by activating the LTD4 receptor.


Subject(s)
Benzene/pharmacology , Granulocyte Colony-Stimulating Factor/physiology , Granulocytes/cytology , Hematopoietic Stem Cells/drug effects , Hydroquinones/pharmacology , Membrane Proteins , Receptors, Leukotriene , Signal Transduction/drug effects , Animals , Arachidonate 5-Lipoxygenase/physiology , Cell Differentiation/drug effects , Cell Division/drug effects , Cell Line , Hematopoiesis/drug effects , Hematopoietic Stem Cells/cytology , Humans , Interleukin-3/pharmacology , Leukemia, Promyelocytic, Acute , Leukotriene Antagonists , Leukotriene D4/biosynthesis , Lipoxygenase Inhibitors , Male , Mice , Mice, Inbred C57BL , Protein Kinase C/antagonists & inhibitors , Protein Kinase C/physiology , Sphingosine/analogs & derivatives , Sphingosine/pharmacology , Tumor Cells, Cultured
14.
Arch Toxicol ; 69(3): 141-8, 1995.
Article in English | MEDLINE | ID: mdl-7717869

ABSTRACT

Chronic exposure of humans to benzene (BZ), a widely used industrial chemical and a ubiquitous environmental pollutant, causes aplastic anemia and acute myeloid leukemia. The purpose of the studies reported here was to determine whether the observed depression of bone marrow (BM) cellularity in mice administered benzene was reflected in a suppression of development of all of the hematopoietic lineages and to confirm the ability of interleukin-1 alpha (IL-1 alpha) to prevent BZ-induced BM cell depression. We report that BZ, administered twice per day for 2 days to C57B1/6J mice at a dose of 600 mg/kg body weight, caused a significant depression of the total number of nucleated BM cells per femur when measured on day 3. The observed depression reflects a complex situation that represents the net effect of a decrease in the total number of cells of the lymphocytic and erythroid lineages, along with an increase in the number of intermediate and terminally differentiated cells of the granulocytic lineage. An experiment to monitor the effects of BZ over a 7-day period showed a progressive depressive effect on the lymphocytes and an initial depression of the erythroid cells at day 3 that remained constant until day 7. Conversely, the numbers of intermediate and terminally differentiated granulocytes progressively increased over the 7 days. The BM appeared to recover from the depressive effects of BZ immediately upon cessation of exposure, as the number of nucleated BM cells began to rise by day 5 and was equal to that of the control group by day 7. The results expand our earlier finding (Renz and Kalf 1991) that the overall depression of BM cellularity occurs because of an inability of the stromal fibroblast to produce colony-stimulating factors essential for stem and progenitor cell survival. This results from inhibition by the BZ metabolite, hydroquinone (HQ), of the processing of pre-IL-1 alpha to the mature cytokine.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Benzene/antagonists & inhibitors , Benzene/toxicity , Hematopoietic Stem Cells/drug effects , Interleukin-1/pharmacology , Animals , Cell Differentiation/drug effects , Hematopoietic Stem Cells/pathology , Male , Mice , Mice, Inbred C57BL
15.
Rom J Physiol ; 32(1-4): 111-7, 1995.
Article in English | MEDLINE | ID: mdl-8896084

ABSTRACT

Researches concerning the variation of correlation coefficient (r) in man in relation to four sets of variables were carried out, namely: a set of ten fundamental variables (in which the dependent variable is represented by aging), a set of variational variables (variation ranks of the r), a set of reference variables (r, age, blood pressure, sex and ABO genetic system) and a set of relational variables (relations). This research contributes to the study of multidimensional variational network of the human gerontogenesis (G. Acilugaritei, 1993-1995).


Subject(s)
Aging/blood , Blood Chemical Analysis/statistics & numerical data , ABO Blood-Group System , Age Distribution , Aged , Aged, 80 and over , Alpha-Globulins/metabolism , Blood Chemical Analysis/standards , Blood Glucose , Blood Pressure , Cholesterol/blood , Female , Hematocrit/standards , Hematocrit/statistics & numerical data , Hemoglobins/standards , Humans , Male , Multivariate Analysis , Reference Values , Serum Albumin , Sex Distribution
16.
Rom J Physiol ; 32(1-4): 119-24, 1995.
Article in English | MEDLINE | ID: mdl-8896085

ABSTRACT

The present paper makes a contribution to the study of the multidimensional variational network of the human gerontogenesis (G. Acalugaritei, 1993-1995). In this respect was rendered evident the variation of the multiple regression coefficient (R) in relation to four sets of variables, as follows: a set of fundamental variables, a set of variational variables (variation ranks of the R), a set of reference variables (R, aging, blood pressure, sex and ABO genetic system) and a set of relational variables (relations).


Subject(s)
Aging/blood , Blood Chemical Analysis/statistics & numerical data , ABO Blood-Group System , Age Distribution , Aged , Aged, 80 and over , Alpha-Globulins/metabolism , Blood Chemical Analysis/standards , Blood Glucose , Blood Pressure , Cholesterol/blood , Female , Hematocrit/standards , Hematocrit/statistics & numerical data , Hemoglobins/standards , Humans , Male , Multivariate Analysis , Reference Values , Regression Analysis , Serum Albumin , Sex Distribution
20.
Virologie ; 35(1): 21-30, 1984.
Article in English | MEDLINE | ID: mdl-6710858

ABSTRACT

A mathematical methodology is suggested which allows the a priori calculation of the risk of premature delivery, by a formula relying on the scores attributed to different specific risk factors (maternal virus infections included). The scores are estimated either directly, or starting from the scores of nonspecific factors. The statistical significance of the different scores, correlations and formulas is analyzed.


Subject(s)
Infant, Premature , Pregnancy Complications , Virus Diseases/complications , Adult , Female , Humans , Infant, Newborn , Obstetric Labor, Premature , Pregnancy , Pregnancy Complications, Infectious , Risk
SELECTION OF CITATIONS
SEARCH DETAIL
...